Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

OASM - Oasmia Pharmaceutical AB ADR

Previous close
1.56
1.560   100.000%

Share volume: 0
Last Updated: Wed 21 Aug 2019 10:00:00 PM CEST
Pharmaceuticals: Other: 0%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
5%
Profitability 0%
Dept financing 9%
Liquidity 5%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$1.56
P/E Ratio 
N/A
DAY RANGE
$1.56 - $1.56
EPS 
-$0.29
52 WEEK RANGE
$0.94 - $5.70
52 WEEK CHANGE
-$15.73
MARKET CAP 
112.451 M
YIELD 
N/A
SHARES OUTSTANDING 
74.967 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$9,910
AVERAGE 30 VOLUME 
$42,990
Company detail
CEO: Sven Rohmann
Region: US
Website: http://www.oasmia.com
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NASDAQ
Industry: Pharmaceuticals: Other
Sector: Health Technology

Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

Recent news